Study of eloralintide for people with persistent obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if adding eloralintide helps people who are still obese or overweight while taking weekly incretin therapy. It aims to support additional weight loss for those who haven't reached their goals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already on a stable weekly incretin medication (like Ozempic or Wegovy).
- You have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as high blood pressure, diabetes, or sleep apnea.
- Your weight has not changed by more than 5% in the past few months.
- You have not had weight-loss surgery or certain weight-loss procedures in the past year.
- You do not have type 1 diabetes and have not used certain diabetes medicines (like insulin) in the last 90 days.
- You have not had a heart attack, stroke, or unstable heart condition in the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
This study tests an investigational medication called eloralintide to see if it can improve sleep apnea in people who are overweight or have obesity. You will receive either the study drug or a placebo (inactive shot), and your sleep and weight will be monitored over time.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.